Macroscopic visualization study of the effects of different anesthetics on cardiovascular function

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2500106138

Enrollment

Unknown

Registered

2025-07-17

Start date

2025-07-17

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiovascular function

Interventions

Propofol(P) group:Propofol 2mg/kg

Etomidate(E)group:Etomidate 0.2mg/kg

Esketamine(S) group:Esketamine 0.5mg/kg

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Patients aged 18 - 70; 2.Surgery under general anesthesia; 3.ASA Class I-III.

Exclusion criteria

Exclusion criteria: 1. Severe cardiovascular disease (congenital heart disease, myocardial infarction, segmental wall motion abnormalities, heart valve disease, pulmonary hypertension, arterial dissection, uncontrolled hypertension, etc.); 2.Diabetes mellitus with peripheral vascular disease; 3.Severe liver and kidney function abnormalities; 4. Central nervous system diseases, mental disorders; 5.Equipped with a pacemaker; 6. Allergy to study drug; 7.Refusal to participate in this study.

Design outcomes

Primary

Measure	Time frame
Cardiac Output;	—

Countries

China

Contacts

Public ContactYouxiu Yao

Peking University Third Hospital

258750040@qq.com+86 188 1048 8772

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026